PT  - JOURNAL ARTICLE
AU  - Chris O’Donnell
AU  - Kate Brownlee
AU  - Elise Martin
AU  - Joe Suyama
AU  - Steve Albert
AU  - Steve Anderson
AU  - Sai Bhatte
AU  - Kenyon Bonner
AU  - Chad Burton
AU  - Micaela Corn
AU  - Heather Eng
AU  - Bethany Flage
AU  - Jay Frerotte
AU  - Goundappa K. Balasubramani
AU  - Catherine Haggerty
AU  - Joel Haight
AU  - Lee H. Harrison
AU  - Amy Hartman
AU  - Thomas Hitter
AU  - Wendy C. King
AU  - Kate Ledger
AU  - Jane W. Marsh
AU  - Margaret C. McDonald
AU  - Bethany Miga
AU  - Kim Moses
AU  - Anne Newman
AU  - Meg Ringler
AU  - Mark Roberts
AU  - Terrie Sax
AU  - Anantha Shekhar
AU  - Matthew Sterne
AU  - Tyler Tenney
AU  - Marian Vanek
AU  - Alan Wells
AU  - Sally Wenzel
AU  - John Williams
TI  - SARS-CoV-2 Control on a Large Urban College Campus Without Mass Testing
AID  - 10.1101/2021.01.21.21249825
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.21.21249825
4099  - http://medrxiv.org/content/early/2021/01/25/2021.01.21.21249825.short
4100  - http://medrxiv.org/content/early/2021/01/25/2021.01.21.21249825.full
AB  - Objective A small percentage of universities and colleges conduct mass SARS-CoV-2 testing. However, universal testing is resource-intensive, strains national testing capacity, and false negative tests can encourage unsafe behaviors.Participants A large urban university campus.Methods Virus control centered on three pillars: mitigation, containment, and communication, with testing of symptomatic and a random subset of asymptomatic students.Results Random surveillance testing demonstrated a prevalence among asymptomatic students of 0.4% throughout the term. There were two surges in cases that were contained by enhanced mitigation and communication combined with targeted testing. Cumulative cases totaled 445 for the term, most resulting from unsafe undergraduate student behavior and among students living off-campus. A case rate of 232/10,000 undergraduates equaled or surpassed several peer institutions that conducted mass testing.Conclusions An emphasis on behavioral mitigation and communication can control virus transmission on a large urban campus combined with a limited and targeted testing strategy.Competing Interest StatementJVW serves on Scientific Advisory Boards for ID Connect and Quidel, and an Independent Data Monitoring Committee for GlaxoSmithKline, none of which are related to this work.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the University of Pittsburgh determined that the proposed activity is not research involving human subjects as defined by DHHS and FDA regulations.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on public dashboard